Literature DB >> 8929724

Endocrine disorders in septo-optic dysplasia (De Morsier syndrome)--evaluation and follow up of 18 patients.

S Willnow1, W Kiess, O Butenandt, H G Dorr, A Enders, B Strasser-Vogel, J Egger, H P Schwarz.   

Abstract

UNLABELLED: Septo-optic dysplasia (SOD) is characterized by hypoplasia of the optic nerve, various types of forebrain defects and hormonal deficiencies. We have studied the clinical and endocrinological characteristics of 18 such patients retrospectively to: (1) better define the endocrine abnormalities in children with SOD; and (2) to find approaches for the interdisciplinary long-term care of children with SOD. The children were seen at the Children's Hospital of the University of Munich from 1976 to 1992 (8 boys, 10 girls; age at initial presentation: 1 day-13 years of age, mean 1.9 years). Unilateral hypoplasia of the optic nerve was found in 7 cases, bilateral hypoplasia in 11. Sonographic, CCT or MRI yielded the following results: 4 of the patients had a cavum septum pellucidum, 3 patients had hypoplasia of the cerebellum, 1 aplasia of the corpus callosum and 1 aplasia of the fornix. An empty sella with or without an ectopic pituitary was seen in 4 cases. Height standard deviation score (SDS) at time of diagnosis was -4.0 to +0.4, mean -2.92. Endocrine deficiencies were present in all 11 patients who had undergone endocrinological investigations. Seven patients suffered from isolated growth hormone (GH) deficiency or multiple hypopituitarism. One had diabetes insipidus centralis, 2 had hypogonadotropic hypogonadism, 1 had hypothyroidism and 2 adrenal insufficiency. Hypothalamic testing was performed only in a subset of patients: in 5 of 11 children tested a thyrotropin releasing hormone (TRH test), in two out of nine a gonadotropin releasing hormone (GnRH) test, and in three out of six GH releasing hormone (GHRH) test yielded abnormal results. High prolactin levels were measured in two out of five patients.
CONCLUSION: SOD is characterized by optic nerve hypoplasia and a variety of endocrine deficiencies. In addition, forebrain malformations are present in most SOD patients. Hormonal disorders are present in some SOD patients which may be of hypothalamic origin and need to be investigated systematically.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8929724     DOI: 10.1007/bf01953934

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  36 in total

1.  Puberty in the syndrome of septo-optic dysplasia.

Authors:  C E Hanna; S H Mandel; S H LaFranchi
Journal:  Am J Dis Child       Date:  1989-02

2.  Physical growth of Swiss children from birth to 20 years of age. First Zurich longitudinal study of growth and development.

Authors:  A Prader; R H Largo; L Molinari; C Issler
Journal:  Helv Paediatr Acta Suppl       Date:  1989-06

3.  Optic hypoplasia and hypopituitarism.

Authors:  F Billson; I J Hopkins
Journal:  Lancet       Date:  1972-04-22       Impact factor: 79.321

4.  Congenital telencephalic midline defects.

Authors:  K Jellinger; H Gross
Journal:  Neuropadiatrie       Date:  1973-12

5.  Septo-optic dysplasia associated with see-saw nystagmus.

Authors:  G V Davis; J P Shock
Journal:  Arch Ophthalmol       Date:  1975-02

6.  Optic nerve hypoplasia with hypopituitarism. Septo-optic dysplasia with hypopituitarism.

Authors:  H Patel; W J Tze; J U Crichton; A Q McCormick; G C Robinson; C L Dolman
Journal:  Am J Dis Child       Date:  1975-02

7.  Arhinencephaly. The spectrum of associated malformations.

Authors:  J A Kobori; M K Herrick; H Urich
Journal:  Brain       Date:  1987-02       Impact factor: 13.501

8.  Septo-optic dysplasia and median cleft face syndrome in a patient with isolated growth hormone deficiency and hyperprolactinemia.

Authors:  C Stewart; M Castro-Magana; J Sherman; M Angulo; P J Collipp
Journal:  Am J Dis Child       Date:  1983-05

9.  Absence of the septum pellucidum. Overlapping clinical syndromes.

Authors:  S A Morgan; H A Emsellem; J R Sandler
Journal:  Arch Neurol       Date:  1985-08

10.  Evolving hypopituitarism in children with central nervous system lesions.

Authors:  C E Hanna; S H LaFranchi
Journal:  Pediatrics       Date:  1983-07       Impact factor: 7.124

View more
  6 in total

Review 1.  HESX1 and Septo-Optic Dysplasia.

Authors:  Mehul Tulsidas Dattani; Iain Caf Robinson
Journal:  Rev Endocr Metab Disord       Date:  2002-12       Impact factor: 6.514

2.  Severe hypernatraemia associated with growth hormone replacement therapy in a patient with septo-optic dysplasia.

Authors:  Shivani Misra; Linda Brown Johnston; William Martyn Drake
Journal:  Pituitary       Date:  2010-06       Impact factor: 4.107

3.  Absence of the septum pellucidum associated with a midline fornical nodule and ventriculomegaly: a report of two cases.

Authors:  Yi Kyeong Chun; Hye Sun Kim; Sung Ran Hong; Je G Chi
Journal:  J Korean Med Sci       Date:  2010-05-24       Impact factor: 2.153

Review 4.  Genetics of septo-optic dysplasia.

Authors:  Daniel Kelberman; Mehul Tulsidas Dattani
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

5.  Activating mutations in BRAF disrupt the hypothalamo-pituitary axis leading to hypopituitarism in mice and humans.

Authors:  Angelica Gualtieri; Nikolina Kyprianou; Louise C Gregory; Maria Lillina Vignola; Mehul T Dattani; Carles Gaston-Massuet; James G Nicholson; Rachael Tan; Shin-Ichi Inoue; Valeria Scagliotti; Pedro Casado; James Blackburn; Fernando Abollo-Jimenez; Eugenia Marinelli; Rachael E J Besser; Wolfgang Högler; I Karen Temple; Justin H Davies; Andrey Gagunashvili; Iain C A F Robinson; Sally A Camper; Shannon W Davis; Pedro R Cutillas; Evelien F Gevers; Yoko Aoki
Journal:  Nat Commun       Date:  2021-04-01       Impact factor: 17.694

Review 6.  Less known aspects of central hypothyroidism: Part 2 - Congenital etiologies.

Authors:  Salvatore Benvenga; Marianne Klose; Roberto Vita; Ulla Feldt-Rasmussen
Journal:  J Clin Transl Endocrinol       Date:  2018-09-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.